NCT06485466
- Conditions
- Apatinib, Camrelizumab, Transarterial Chemoembolization, +1 more
- Locations
-
- Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China
Clinical trial condition
Camrelizumab
Explore clinical trials studying Camrelizumab. Study availability and eligibility vary by location and protocol.
5 public trials
4 recruiting studies
Camrelizumab trial results
NCT05512481
- Conditions
- Acral Melanoma, Apatinib, Camrelizumab, +15 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
NCT05475678
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Henan cancer hospital Zhengzhou, Henan, China
NCT06061276
- Conditions
- Adenocarcinoma, Camrelizumab, Carcinoma, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China
Not Yet Recruiting
A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
NCT06276933
- Conditions
- Camrelizumab, Lung Cancer, Lung Diseases, +6 more
- Locations
-
Not specified